Neide Barreto da Silva Lisboa, Jozélio Freire de Carvalho
{"title":"维生素 D 补充剂对重症患者死亡率的影响:系统回顾和荟萃分析。","authors":"Neide Barreto da Silva Lisboa, Jozélio Freire de Carvalho","doi":"10.9771/cmbio.v22i4.54199","DOIUrl":null,"url":null,"abstract":"Objective: This study aimed to use a meta-analysis to evaluate whether vitamin D supplementation can improve critically ill patients' parameters.Materials and Methods: A systematic review of the literature and meta-analysis was performed using the electronic databases PubMed, Cochrane, Medline, and Scielo. The selected studies are randomized controlled trials (RCTs) that evaluate the effect of vitamin D supplementation in critically ill patients over 18 years of age and are available in full. All of the articles involved randomized clinical trials that analyzed the effects of vitamin supplementation on mortality, length of ICU stay, length of hospital stay, and use of mechanical ventilation. \nResults: The meta-analysis revealed that vitamin D supplementation in critically ill patients can reduce mortality in 28-30 days [RR =0.76 (95%CI: 0.57-1.00, p=0.05)] (p=0.85), hospital mortality (p=0.14), length of ICU stays (p=0.11), length of hospital stays (p=0.08) and time of mechanical ventilation (p=0.32).Conclusion: This meta-analysis demonstrated that vitamin D supplements in critically ill patients show a reduction in mortality in 28-30 days. Thus, it is suggested that critically ill patients who are 18 years of age or older should receive a dose of vitamin D greater than 150,000IU to obtain this benefit.","PeriodicalId":21339,"journal":{"name":"Revista de Ciências Médicas e Biológicas","volume":"186 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of vitamin D supplementation on mortality in critically ill patients: a systematic review and meta-analysis.\",\"authors\":\"Neide Barreto da Silva Lisboa, Jozélio Freire de Carvalho\",\"doi\":\"10.9771/cmbio.v22i4.54199\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: This study aimed to use a meta-analysis to evaluate whether vitamin D supplementation can improve critically ill patients' parameters.Materials and Methods: A systematic review of the literature and meta-analysis was performed using the electronic databases PubMed, Cochrane, Medline, and Scielo. The selected studies are randomized controlled trials (RCTs) that evaluate the effect of vitamin D supplementation in critically ill patients over 18 years of age and are available in full. All of the articles involved randomized clinical trials that analyzed the effects of vitamin supplementation on mortality, length of ICU stay, length of hospital stay, and use of mechanical ventilation. \\nResults: The meta-analysis revealed that vitamin D supplementation in critically ill patients can reduce mortality in 28-30 days [RR =0.76 (95%CI: 0.57-1.00, p=0.05)] (p=0.85), hospital mortality (p=0.14), length of ICU stays (p=0.11), length of hospital stays (p=0.08) and time of mechanical ventilation (p=0.32).Conclusion: This meta-analysis demonstrated that vitamin D supplements in critically ill patients show a reduction in mortality in 28-30 days. Thus, it is suggested that critically ill patients who are 18 years of age or older should receive a dose of vitamin D greater than 150,000IU to obtain this benefit.\",\"PeriodicalId\":21339,\"journal\":{\"name\":\"Revista de Ciências Médicas e Biológicas\",\"volume\":\"186 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista de Ciências Médicas e Biológicas\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9771/cmbio.v22i4.54199\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de Ciências Médicas e Biológicas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9771/cmbio.v22i4.54199","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
研究目的本研究旨在通过荟萃分析评估补充维生素 D 是否能改善重症患者的各项指标:利用电子数据库 PubMed、Cochrane、Medline 和 Scielo 对文献进行了系统回顾和荟萃分析。所选研究均为随机对照试验(RCT),这些试验对 18 岁以上重症患者补充维生素 D 的效果进行了评估,并提供了全文。所有文章均涉及随机临床试验,分析了补充维生素对死亡率、重症监护室住院时间、住院时间和机械通气的影响。结果显示荟萃分析显示,重症患者补充维生素 D 可降低 28-30 天内的死亡率[RR =0.76 (95%CI: 0.57-1.00, p=0.05)](p=0.85)、住院死亡率(p=0.14)、重症监护室停留时间(p=0.11)、住院时间(p=0.08)和机械通气时间(p=0.32):这项荟萃分析表明,重症患者补充维生素 D 可降低 28-30 天内的死亡率。因此,建议 18 岁或以上的重症患者应摄入大于 150,000IU 的维生素 D,以获得这一益处。
Effects of vitamin D supplementation on mortality in critically ill patients: a systematic review and meta-analysis.
Objective: This study aimed to use a meta-analysis to evaluate whether vitamin D supplementation can improve critically ill patients' parameters.Materials and Methods: A systematic review of the literature and meta-analysis was performed using the electronic databases PubMed, Cochrane, Medline, and Scielo. The selected studies are randomized controlled trials (RCTs) that evaluate the effect of vitamin D supplementation in critically ill patients over 18 years of age and are available in full. All of the articles involved randomized clinical trials that analyzed the effects of vitamin supplementation on mortality, length of ICU stay, length of hospital stay, and use of mechanical ventilation.
Results: The meta-analysis revealed that vitamin D supplementation in critically ill patients can reduce mortality in 28-30 days [RR =0.76 (95%CI: 0.57-1.00, p=0.05)] (p=0.85), hospital mortality (p=0.14), length of ICU stays (p=0.11), length of hospital stays (p=0.08) and time of mechanical ventilation (p=0.32).Conclusion: This meta-analysis demonstrated that vitamin D supplements in critically ill patients show a reduction in mortality in 28-30 days. Thus, it is suggested that critically ill patients who are 18 years of age or older should receive a dose of vitamin D greater than 150,000IU to obtain this benefit.